glp-1 and pain Advances in receptor agonists for treatment their future potential | The Journal of Headache and Pain glp 1 and leg pain

If thigh injection reduces nausea enough to keep you compliant with your protocol, the slightly slower absorption becomes irrelevant compared to the benefit of actually staying on treatment

This strategy has been exploited in the long-acting GLP-1RA semaglutide (Novo Nordisk), for instance, which was approved for treatment of T2DM in 2017, and for treatment of obesity in 2021, and has since then become the most prescribed GLP-1RA 92

Early weight loss is often driven by eating less and making different food choices

J.ParkH

This principle is likely to guide future medication development as researchers explore triple agonists and other multi-targeted approaches

Effects of repeated green tea catechin administration on human cytochrome P450 activity